Dr. Farhat, TPICO’s new Managing Director
Dr. Mohammad Rezvanifar, CEO of Social Security Investment Company (SSIC), has appointed Dr. Pouya Farhat as the representative of the Social Security Investment Company (SSIC) in the Board of Directors and the new CEO of Tamin Pharmaceutical Investment Company (TPICO).
Dr. Pouya Farhat, 39, has a Doctorate in Pharmacy from the University of Tehran and a Master's degree in Business from Shahid Beheshti University of Medical Sciences with 17 years of continuous experience in pharmaceutical industry.
In his first official statement since being appointed as Tpico's CEO, Dr. Farhat said: "Tpico will continue to grow more rapidly just like its trend in last year."
Farhat added: "I have accepted this responsibility with optimism and hope for the future, and with the approval of Dr. Rezvanifar's reforms in the past year, I will continue the same process; I have seen the trends growing in Tpico and I will do my best to maintain and develop the balance and harmony in holding.